{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:45:26Z","timestamp":1794890726598,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,1,7]],"date-time":"2010-01-07T00:00:00Z","timestamp":1262822400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00277-009-0869-5","type":"journal-article","created":{"date-parts":[[2010,1,6]],"date-time":"2010-01-06T03:45:56Z","timestamp":1262749556000},"page":"459-467","source":"Crossref","is-referenced-by-count":16,"title":["Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML"],"prefix":"10.1007","volume":"89","author":[{"given":"Christian","family":"Koenecke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"K\u00fcmpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lukasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Dammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"G\u00f6hring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Krauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Schlegelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,7]]},"reference":[{"key":"869_CR1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.beha.2006.10.002","volume":"20","author":"F Dazzi","year":"2007","unstructured":"Dazzi F, Fozza C (2007) Disease relapse after haematopoietic stem cell transplantation: risk factors and treatment. Best Pract Res Clin Haematol 20:311\u2013327","journal-title":"Best Pract Res Clin Haematol"},{"key":"869_CR2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bmt.1701672","volume":"23","author":"AH Elmaagacli","year":"1999","unstructured":"Elmaagacli AH, Beelen DW, Trenn G, Schmidt O, Nahler M, Schaefer UW (1999) Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation. Bone Marrow Transplant 23:771\u2013777","journal-title":"Bone Marrow Transplant"},{"key":"869_CR3","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1200\/JCO.2005.07.061","volume":"23","author":"C Schmid","year":"2005","unstructured":"Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ (2005) Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol 23:5675\u20135687","journal-title":"J Clin Oncol"},{"key":"869_CR4","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa074306","volume":"358","author":"RF Schlenk","year":"2008","unstructured":"Schlenk RF, Dohner K, Krauter J, Frohling S, Corbacioglu A, Bullinger L, Habdank M, Spath D, Morgan M, Benner A, Schlegelberger B, Heil G, Ganser A, Dohner H (2008) Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 358:1909\u20131918","journal-title":"N Engl J Med"},{"key":"869_CR5","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","volume":"92","author":"D Grimwade","year":"1998","unstructured":"Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1, 612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children\u2019s Leukaemia Working Parties. Blood 92:2322\u20132333","journal-title":"Blood"},{"key":"869_CR6","first-page":"21","volume":"26","author":"WJ Edenfield","year":"1999","unstructured":"Edenfield WJ, Gore SD (1999) Stage-specific application of allogeneic and autologous marrow transplantation in the management of acute myeloid leukemia. Semin Oncol 26:21\u201334","journal-title":"Semin Oncol"},{"key":"869_CR7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/sj.leu.2401568","volume":"14","author":"EH Estey","year":"2000","unstructured":"Estey EH (2000) Treatment of relapsed and refractory acute myelogenous leukemia. Leukemia 14:476\u2013479","journal-title":"Leukemia"},{"key":"869_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353\u2013364","journal-title":"Cell"},{"key":"869_CR9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/152581602753448522","volume":"11","author":"SV Rajkumar","year":"2002","unstructured":"Rajkumar SV, Mesa RA, Tefferi A (2002) A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies. J Hematother Stem Cell Res 11:33\u201347","journal-title":"J Hematother Stem Cell Res"},{"key":"869_CR10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2008.07372.x","volume":"143","author":"WW Li","year":"2008","unstructured":"Li WW, Hutnik M, Gehr G (2008) Antiangiogenesis in haematological malignancies. Br J Haematol 143:622\u2013631","journal-title":"Br J Haematol"},{"issue":"Suppl 2","key":"869_CR11","first-page":"S72","volume":"81","author":"RM Mesters","year":"2002","unstructured":"Mesters RM (2002) Angiogenesis in hematologic malignancies. Ann Hematol 81(Suppl 2):S72\u2013S74","journal-title":"Ann Hematol"},{"key":"869_CR12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1200\/JCO.2005.05.058","volume":"23","author":"S Loges","year":"2005","unstructured":"Loges S, Heil G, Bruweleit M, Schoder V, Butzal M, Fischer U, Gehling UM, Schuch G, Hossfeld DK, Fiedler W (2005) Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival. J Clin Oncol 23:1109\u20131117","journal-title":"J Clin Oncol"},{"key":"869_CR13","first-page":"7241","volume":"63","author":"R Bieker","year":"2003","unstructured":"Bieker R, Padro T, Kramer J, Steins M, Kessler T, Retzlaff S, Herrera F, Kienast J, Berdel WE, Mesters RM (2003) Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia. Cancer Res 63:7241\u20137246","journal-title":"Cancer Res"},{"key":"869_CR14","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/01.RES.0000218275.54089.12","volume":"98","author":"NP Brindle","year":"2006","unstructured":"Brindle NP, Saharinen P, Alitalo K (2006) Signaling and functions of angiopoietin-1 in vascular protection. Circ Res 98:1014\u20131023","journal-title":"Circ Res"},{"key":"869_CR15","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1074\/jbc.M208550200","volume":"278","author":"U Fiedler","year":"2003","unstructured":"Fiedler U, Krissl T, Koidl S, Weiss C, Koblizek T, Deutsch U, Martiny-Baron G, Marme D, Augustin HG (2003) Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J Biol Chem 278:1721\u20131727","journal-title":"J Biol Chem"},{"key":"869_CR16","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/labinvest.3700476","volume":"86","author":"S Wakui","year":"2006","unstructured":"Wakui S, Yokoo K, Muto T, Suzuki Y, Takahashi H, Furusato M, Hano H, Endou H, Kanai Y (2006) Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis. Lab Invest 86:1172\u20131184","journal-title":"Lab Invest"},{"key":"869_CR17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/01.RES.81.4.567","volume":"81","author":"AL Wong","year":"1997","unstructured":"Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG (1997) Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 81:567\u2013574","journal-title":"Circ Res"},{"key":"869_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrm2639","volume":"10","author":"HG Augustin","year":"2009","unstructured":"Augustin HG, Koh GY, Thurston G, Alitalo K (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10:165\u2013177","journal-title":"Nat Rev Mol Cell Biol"},{"key":"869_CR19","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1161\/01.CIR.0000102939.04279.75","volume":"108","author":"NP Fam","year":"2003","unstructured":"Fam NP, Verma S, Kutryk M, Stewart DJ (2003) Clinician guide to angiogenesis. Circulation 108:2613\u20132618","journal-title":"Circulation"},{"key":"869_CR20","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/01.CIR.101.19.2317","volume":"101","author":"HJ Kwak","year":"2000","unstructured":"Kwak HJ, Lee SJ, Lee YH, Ryu CH, Koh KN, Choi HY, Koh GY (2000) Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. Circulation 101:2317\u20132324","journal-title":"Circulation"},{"key":"869_CR21","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/01.CIR.0000054623.35669.3F","volume":"107","author":"AI Nykanen","year":"2003","unstructured":"Nykanen AI, Krebs R, Saaristo A, Turunen P, Alitalo K, Yla-Herttuala S, Koskinen PK, Lemstrom KB (2003) Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation 107:1308\u20131314","journal-title":"Circulation"},{"key":"869_CR22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.CIR.0000151287.08202.8E","volume":"111","author":"B Witzenbichler","year":"2005","unstructured":"Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C (2005) Protective role of angiopoietin-1 in endotoxic shock. Circulation 111:97\u2013105","journal-title":"Circulation"},{"key":"869_CR23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/cc7153","volume":"13","author":"M Meurs van","year":"2009","unstructured":"van Meurs M, Kumpers P, Ligtenberg JJ, Meertens JH, Molema G, Zijlstra JG (2009) Bench-to-bedside review: angiopoietin signalling in critical illness\u2014a future target? Crit Care 13:207","journal-title":"Crit Care"},{"key":"869_CR24","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2003-10-3685","volume":"103","author":"U Fiedler","year":"2004","unstructured":"Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, Schmidt JM, Kriz W, Thurston G, Augustin HG (2004) The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel\u2013Palade bodies. Blood 103:4150\u20134156","journal-title":"Blood"},{"key":"869_CR25","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0002-9440(10)65079-1","volume":"156","author":"SJ Mandriota","year":"2000","unstructured":"Mandriota SJ, Pyke C, Di Sanza C, Quinodoz P, Pittet B, Pepper MS (2000) Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia. Am J Pathol 156:2077\u20132089","journal-title":"Am J Pathol"},{"key":"869_CR26","doi-asserted-by":"crossref","first-page":"12171","DOI":"10.1074\/jbc.M305146200","volume":"279","author":"P Pichiule","year":"2004","unstructured":"Pichiule P, Chavez JC, LaManna JC (2004) Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J Biol Chem 279:12171\u201312180","journal-title":"J Biol Chem"},{"key":"869_CR27","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1172\/JCI0214105","volume":"109","author":"P Vajkoczy","year":"2002","unstructured":"Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G (2002) Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest 109:777\u2013785","journal-title":"J Clin Invest"},{"key":"869_CR28","first-page":"7124","volume":"62","author":"F Tanaka","year":"2002","unstructured":"Tanaka F, Ishikawa S, Yanagihara K, Miyahara R, Kawano Y, Li M, Otake Y, Wada H (2002) Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res 62:7124\u20137129","journal-title":"Cancer Res"},{"key":"869_CR29","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ijc.10851","volume":"103","author":"C Sfiligoi","year":"2003","unstructured":"Sfiligoi C, de Luca A, Cascone I, Sorbello V, Fuso L, Ponzone R, Biglia N, Audero E, Arisio R, Bussolino F, Sismondi P, De Bortoli M (2003) Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer 103:466\u2013474","journal-title":"Int J Cancer"},{"key":"869_CR30","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2404820","volume":"21","author":"C Schliemann","year":"2007","unstructured":"Schliemann C, Bieker R, Thoennissen N, Gerss J, Liersch R, Kessler T, Buchner T, Berdel WE, Mesters RM (2007) Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia. Leukemia 21:1901\u20131906","journal-title":"Leukemia"},{"key":"869_CR31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bjc.6603966","volume":"97","author":"CY Lee","year":"2007","unstructured":"Lee CY, Tien HF, Hu CY, Chou WC, Lin LI (2007) Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia. Br J Cancer 97:877\u2013882","journal-title":"Br J Cancer"},{"key":"869_CR32","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1182\/blood-2007-12-130021","volume":"112","author":"P Kumpers","year":"2008","unstructured":"Kumpers P, Koenecke C, Hecker H, Hellpap J, Horn R, Verhagen W, Buchholz S, Hertenstein B, Krauter J, Eder M, David S, Gohring G, Haller H, Ganser A (2008) Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies. Blood 112:2139\u20132148","journal-title":"Blood"},{"key":"869_CR33","doi-asserted-by":"crossref","first-page":"23910","DOI":"10.1074\/jbc.M702169200","volume":"282","author":"T Mammoto","year":"2007","unstructured":"Mammoto T, Parikh SM, Mammoto A, Gallagher D, Chan B, Mostoslavsky G, Ingber DE, Sukhatme VP (2007) Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem 282:23910\u201323918","journal-title":"J Biol Chem"},{"key":"869_CR34","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.105.086553","volume":"314","author":"F Roviezzo","year":"2005","unstructured":"Roviezzo F, Tsigkos S, Kotanidou A, Bucci M, Brancaleone V, Cirino G, Papapetropoulos A (2005) Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther 314:738\u2013744","journal-title":"J Pharmacol Exp Ther"},{"key":"869_CR35","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/MCB.01472-08","volume":"29","author":"HT Yuan","year":"2009","unstructured":"Yuan HT, Khankin EV, Karumanchi SA, Parikh SM (2009) Angiopoietin 2 is a partial agonist\/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 29:2011\u20132022","journal-title":"Mol Cell Biol"},{"key":"869_CR36","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/ATVBAHA.107.150482","volume":"27","author":"CM Findley","year":"2007","unstructured":"Findley CM, Cudmore MJ, Ahmed A, Kontos CD (2007) VEGF induces Tie2 shedding via a phosphoinositide 3-kinase\/Akt dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol 27:2619\u20132626","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"869_CR37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1012226627813","volume":"4","author":"P Reusch","year":"2001","unstructured":"Reusch P, Barleon B, Weindel K, Martiny-Baron G, Godde A, Siemeister G, Marme D (2001) Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis 4:123\u2013131","journal-title":"Angiogenesis"},{"key":"869_CR38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/rp.59.1.51","volume":"59","author":"KG Peters","year":"2004","unstructured":"Peters KG, Kontos CD, Lin PC, Wong AL, Rao P, Huang L, Dewhirst MW, Sankar S (2004) Functional significance of Tie2 signaling in the adult vasculature. Recent Prog Horm Res 59:51\u201371","journal-title":"Recent Prog Horm Res"},{"key":"869_CR39","first-page":"773","volume":"23","author":"V Martin","year":"2008","unstructured":"Martin V, Liu D, Fueyo J, Gomez-Manzano C (2008) Tie2: a journey from normal angiogenesis to cancer and beyond. Histol Histopathol 23:773\u2013780","journal-title":"Histol Histopathol"},{"key":"869_CR40","first-page":"1992","volume":"7","author":"AL Harris","year":"2001","unstructured":"Harris AL, Reusch P, Barleon B, Hang C, Dobbs N, Marme D (2001) Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy. Clin Cancer Res 7:1992\u20131997","journal-title":"Clin Cancer Res"},{"key":"869_CR41","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","volume":"96","author":"ML Slovak","year":"2000","unstructured":"Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, Paietta E, Willman CL, Head DR, Rowe JM, Forman SJ, Appelbaum FR (2000) Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study. Blood 96:4075\u20134083","journal-title":"Blood"},{"key":"869_CR42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.leu.2401241","volume":"13","author":"T Iwai","year":"1999","unstructured":"Iwai T, Yokota S, Nakao M, Okamoto T, Taniwaki M, Onodera N, Watanabe A, Kikuta A, Tanaka A, Asami K, Sekine I, Mugishima H, Nishimura Y, Koizumi S, Horikoshi Y, Mimaya J, Ohta S, Nishikawa K, Iwai A, Shimokawa T, Nakayama M, Kawakami K, Gushiken T, Hyakuna N, Fujimoto T et al (1999) Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children\u2019s Cancer and Leukemia Study Group, Japan. Leukemia 13:38\u201343","journal-title":"Leukemia"},{"key":"869_CR43","first-page":"3074","volume":"93","author":"H Kiyoi","year":"1999","unstructured":"Kiyoi H, Naoe T, Nakano Y, Yokota S, Minami S, Miyawaki S, Asou N, Kuriyama K, Jinnai I, Shimazaki C, Akiyama H, Saito K, Oh H, Motoji T, Omoto E, Saito H, Ohno R, Ueda R (1999) Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 93:3074\u20133080","journal-title":"Blood"},{"issue":"4","key":"869_CR44","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1158\/0008-5472.CAN-08-3030","volume":"69","author":"P Nasarre","year":"2009","unstructured":"Nasarre P, Thomas M, Kruse K, Helfrich I, Wolter V, Deppermann C, Schadendorf D, Thurston G, Fiedler U, Augustin HG (2009) Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth. Cancer Res 69(4):1324\u20131333","journal-title":"Cancer Res"},{"key":"869_CR45","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.leukres.2007.08.010","volume":"32","author":"HA Hou","year":"2008","unstructured":"Hou HA, Chou WC, Lin LI, Tang JL, Tseng MH, Huang CF, Yao M, Chen CY, Tsay W, Tien HF (2008) Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia. Leuk Res 32:904\u2013912","journal-title":"Leuk Res"},{"key":"869_CR46","first-page":"1203","volume":"91","author":"C Schliemann","year":"2006","unstructured":"Schliemann C, Bieker R, Padro T, Kessler T, Hintelmann H, Buchner T, Berdel WE, Mesters RM (2006) Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia. Haematologica 91:1203\u20131211","journal-title":"Haematologica"},{"key":"869_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1618","volume":"204","author":"CR Tait","year":"2004","unstructured":"Tait CR, Jones PF (2004) Angiopoietins in tumours: the angiogenic switch. J Pathol 204:1\u201310","journal-title":"J Pathol"},{"key":"869_CR48","doi-asserted-by":"crossref","unstructured":"van der Heijden M, van Nieuw Amerongen GP, van Hinsbergh VW, Groeneveld AJ (2009) The interaction of soluble Tie2 with angiopoietins and pulmonary vascular permeability in septic and non-septic critically ill patients. Shock (in press). doi: 10.1097\/SHK.0b013e3181b2f978","DOI":"10.1097\/SHK.0b013e3181b2f978"},{"key":"869_CR49","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/cc7130","volume":"12","author":"P Kumpers","year":"2008","unstructured":"Kumpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT (2008) Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 12:R147","journal-title":"Crit Care"},{"key":"869_CR50","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1158\/1078-0432.CCR-06-2509","volume":"13","author":"DC Gallagher","year":"2007","unstructured":"Gallagher DC, Bhatt RS, Parikh SM, Patel P, Seery V, McDermott DF, Atkins MB, Sukhatme VP (2007) Angiopoietin 2 is a potential mediator of high-dose interleukin 2-induced vascular leak. Clin Cancer Res 13:2115\u20132120","journal-title":"Clin Cancer Res"},{"issue":"6","key":"869_CR51","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/ndt\/gfn755","volume":"24","author":"P Kumpers","year":"2009","unstructured":"Kumpers P, Hellpap J, David S, Horn R, Leitolf H, Haller H, Haubitz M (2009) Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvement. Nephrol Dial Transplant 24(6):1845\u20131850","journal-title":"Nephrol Dial Transplant"},{"issue":"21","key":"869_CR52","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1200\/JCO.2008.19.6683","volume":"27","author":"RS Herbst","year":"2009","unstructured":"Herbst RS, Hong D, Chap L, Kurzrock R, Jackson E, Silverman JM, Rasmussen E, Sun YN, Zhong D, Hwang YC, Evelhoch JL, Oliner JD, Le N, Rosen LS (2009) Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors. J Clin Oncol 27(21):3557\u201365","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0869-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-009-0869-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0869-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T12:27:34Z","timestamp":1590496054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-009-0869-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,7]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1007\/s00277-009-0869-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,7]]}}}